LivaNova (LIVN) Non Operating Investment Income (2017 - 2018)
LivaNova's (LIVN) quarterly Non Operating Investment Income came in at $11.5 million in Q1 2018, down 70.87% quarter-over-quarter from $39.4 million in Q2 2017.
Powered by 
Analysis
LivaNova (LIVN) Non Operating Investment Income (2017 - 2018) Analysis & Trends
LivaNova has disclosed Non Operating Investment Income across 2 years of filings, most recently posting $11.5 million for Q1 2018.
- In Q1 2018, Non Operating Investment Income changed N/A year-over-year to $11.5 million; the TTM figure through Dec 2018 stood at $11.5 million (down 70.87% YoY), while the FY2018 annual figure was $11.5 million, down 70.87% from the prior year.
- Non Operating Investment Income came in at $11.5 million for Q1 2018 at LivaNova, down from $39.4 million in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $39.4 million in Q2 2017 to a low of $11.5 million in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn | - |